Marie-Hélène Delfau
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 10
- Dermatology top 10%
- Cutaneous lymphoproliferative disorders research 2
-
- Chronic Lymphocytic Leukemia Research 3
-
- CAR-T cell therapy research 3
- Viral-associated cancers and disorders 2
- Vascular Tumors and Angiosarcomas 1
-
- Porphyrin Metabolism and Disorders 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Philippe GaulardBernard GrandchampY NordmannHubert de VerneuilJean‐Charles DeybachLaura PelletierNicolás OrtonneOlivier Hermine
- Journals
- Blood (6 papers)The American Journal of Surgical Pathology (1 paper)The Journal of Pathology (2 papers)
- Partner nations
- FranceGermanyNetherlands
In The Last Decade
Marie-Hélène Delfau
14 papers receiving 209 citations
Peers
Comparison fields: 5 of 30
- Pathology and Forensic Medicine 150
- Dermatology 65
- Genetics 56
- Oncology 114
- Immunology 51
Countries citing papers authored by Marie-Hélène Delfau
This map shows the geographic impact of Marie-Hélène Delfau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie-Hélène Delfau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie-Hélène Delfau more than expected).
Fields of papers citing papers by Marie-Hélène Delfau
This network shows the impact of papers produced by Marie-Hélène Delfau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie-Hélène Delfau. The network helps show where Marie-Hélène Delfau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marie-Hélène Delfau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 28 | |
| 7 | 2018 | 2 | |
| 8 | 2015 | 14 | |
| 9 | 2010 | 26 | |
| 10 | 2008 | 13 | |
| 11 | 1996 | 91 | |
| 12 | 1996 | 3 | |
| 13 | 1990 | 18 | |
| 14 | 1989 | 1 |
About Marie-Hélène Delfau
Marie-Hélène Delfau is a scholar working on Pathology and Forensic Medicine, Genetics and Dermatology, having authored 14 papers that have together received 213 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Porphyrin Metabolism and Disorders (2 papers), Viral-associated cancers and disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (150 citations), Dermatology (65 citations) and Genetics (56 citations). Marie-Hélène Delfau has collaborated with scholars based in France, Germany and Netherlands. Frequent co-authors include Philippe Gaulard, Bernard Grandchamp, Y Nordmann, Hubert de Verneuil, Jean‐Charles Deybach, Laura Pelletier, Nicolás Ortonne, Olivier Hermine, Catherine Godfraind and F. Franck. Their work appears in journals such as Blood, The American Journal of Surgical Pathology and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.